Skip to main content
. 2018 Nov 9;2018(11):CD006495. doi: 10.1002/14651858.CD006495.pub5

Summary of findings for the main comparison. Resistance testing versus no resistance testing in HIV‐positive people.

Resistance testing versus no resistance testing in HIV‐positive people
Patient or population: HIV‐positive people
 Setting: all settings
 Intervention: resistance testing
 Comparison: no resistance testing
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) Number of participants
 (trials) Certainty of the evidence
 (GRADE) Comments
Risk with no resistance testing Risk with resistance testing
Mortality Study population OR 0.89
 (0.36 to 2.22) 1140
 (5 RCTs) ⊕⊕⊕⊝
 MODERATEa,b,c
Due to imprecision
Resistance testing probably has little or no impact on mortality
22 per 1000 20 per 1000
 (8 to 47)
Virological failure Study population OR 0.70
 (0.56 to 0.87) 1728
 (10 RCTs) ⊕⊕⊝⊝
 LOWa,d,e,f
Due to risk of bias and publication bias
Resistance testing may reduce the risk of virological failure
660 per 1000 576 per 1000
 (521 to 628)
Change in CD4 cell count Mean change in CD4 cell count was 0. MD 1 lower
 (12.49 lower to 10.5 higher) 1349
 (7 RCTs) ⊕⊕⊕⊝
 MODERATEa,d
Due to risk of bias
Resistance testing probably has little or no effect on change in CD4 cell count
Progression to AIDS Study population OR 0.64
 (0.31 to 1.29) 809
 (3 RCTs) ⊕⊕⊕⊝
 MODERATEg
Due to indirectness
Resistance testing probably has little or no impact on progression to AIDS
67 per 1000 44 per 1000
 (22 to 85)
Adverse events Study population OR 0.89
 (0.51 to 1.55) 808
 (4 RCTs) ⊕⊕⊝⊝
 LOWh,i
Due to risk of bias and indirectness
Resistance testing may have little or no effect on adverse effects
74 per 1000 66 per 1000
 (39 to 110)
Change in viral load Mean change in viral load was 0. MD 0.23 lower
 (0.35 lower to 0.11 lower) 1837
 (10 RCTs) ⊕⊕⊕⊝
 MODERATEa,j
Due to risk of bias
Resistance testing probably results in a lower viral load
Quality of life ‐ not reported
New opportunistic infection ‐ not reported
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 Abbreviations: CI: confidence interval; MD: mean difference; OR: odds ratio; RCT: randomized controlled trial
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect
 Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
 Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

aRisk of bias: all studies included for this outcome were not blinded, but we did not downgrade for this, as lack of blinding is unlikely to introduce bias.
 bRisk of bias: one included study was at high risk of bias overall, but it contributed 16.1% of the data (Wegner 2004). We did not downgrade for this.
 cDowngraded by 1 for imprecision: CIs for the odds ratio include considerable harm and considerable benefit. We downgraded one point for this.
 dDowngraded by 1 for risk of bias: four of the included studies (˜ 37% of data) were at high or unclear risk of bias (Cingolani 2002;Cohen 2002;Haubrich 2005;Rubini 2002).
 eIndirectness: the included studies used different cutoffs to define virological failure. We did not downgrade for this.
 fDowngraded by 1 for publication bias: based on funnel plot asymmetry and a positive Egger's test.
 gDowngraded by 1 for indirectness: "progression to AIDS" was not defined uniformly across studies.
 hDowngraded by 1 for risk of bias: all studies included for this outcome were not blinded and adverse events could be interpreted subjectively.
 iDowngraded by 1 for indirectness: "adverse event" was not defined uniformly across studies. We downgraded one point for this.
 jDowngraded by 1 for risk of bias: four of the included studies (˜ 34% of data) were at high or unclear risk of bias (Cingolani 2002;Cohen 2002;Haubrich 2005;Rubini 2002).